Literature DB >> 9525648

Evidence of a role for phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen.

J Dahl1, A Jurczak, L A Cheng, D C Baker, T L Benjamin.   

Abstract

A polyomavirus mutant (315YF) blocked in binding phosphatidylinositol 3-kinase (PI 3-kinase) has previously been shown to be partially deficient in transformation and to induce fewer tumors and with a significant delay compared to wild-type virus. The role of polyomavirus middle T antigen-activated PI 3-kinase in apoptosis was investigated as a possible cause of this behavior. When grown in medium containing 1D-3-deoxy-3-fluoro-myo-inositol to block formation of 3'-phosphorylated phosphatidylinositols, F111 rat fibroblasts transformed by wild-type polyomavirus (PyF), but not normal F111 cells, showed a marked loss of viability with evidence of apoptosis. Similarly, treatment with wortmannin, an inhibitor of PI 3-kinase, stimulated apoptosis in PyF cells but not in normal cells. Activation of Akt, a serine/threonine kinase whose activity has been correlated with regulation of apoptosis, was roughly twofold higher in F111 cells transformed by either wild-type virus or mutant 250YS blocked in binding Shc compared to cells transformed by mutant 315YF. In the same cells, levels of apoptosis were inversely correlated with Akt activity. Apoptosis induced by serum withdrawal in Rat-1 cells expressing a temperature-sensitive p53 was shown to be at least partially p53 independent. Expression of either wild-type or 250YS middle T antigen inhibited apoptosis in serum-starved Rat-1 cells at both permissive and restrictive temperatures for p53. Mutant 315YF middle T antigen was partially defective for inhibition of apoptosis in these cells. The results indicate that unlike other DNA tumor viruses which block apoptosis by inactivation of p53, polyomavirus achieves protection from apoptotic death through a middle T antigen-PI 3-kinase-Akt pathway that is at least partially p53 independent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525648      PMCID: PMC109788     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc.

Authors:  R Bronson; C Dawe; J Carroll; T Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Recruitment of p300/CBP in p53-dependent signal pathways.

Authors:  M L Avantaggiati; V Ogryzko; K Gardner; A Giordano; A S Levine; K Kelly
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

Review 3.  Apoptosis by death factor.

Authors:  S Nagata
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

4.  Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation.

Authors:  Y C Cai; D Cefai; H Schneider; M Raab; N Nabavi; C E Rudd
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

Review 5.  Apoptosis in viral infections.

Authors:  E S Razvi; R M Welsh
Journal:  Adv Virus Res       Date:  1995       Impact factor: 9.937

6.  Wild-type p53 modulates apoptosis of normal, IL-3 deprived, hematopoietic cells.

Authors:  G Blandino; R Scardigli; M G Rizzo; M Crescenzi; S Soddu; A Sacchi
Journal:  Oncogene       Date:  1995-02-16       Impact factor: 9.867

7.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.

Authors:  R Yao; G M Cooper
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

8.  Polyomavirus large T antigen overcomes p53 dependent growth arrest.

Authors:  J Doherty; R Freund
Journal:  Oncogene       Date:  1997-04-24       Impact factor: 9.867

9.  The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

Authors:  S G Kennedy; A J Wagner; S D Conzen; J Jordán; A Bellacosa; P N Tsichlis; N Hay
Journal:  Genes Dev       Date:  1997-03-15       Impact factor: 11.361

10.  Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.

Authors:  B M Burgering; P J Coffer
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

View more
  27 in total

Review 1.  Phosphatidylinositol 3' kinase signaling in mammary tumorigenesis.

Authors:  M P Scheid; J R Woodgett
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

Review 2.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

3.  Induction and utilization of an ATM signaling pathway by polyomavirus.

Authors:  Jean Dahl; John You; Thomas L Benjamin
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 4.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

5.  A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.

Authors:  Deborah Denis; Cecile Rouleau; Brian S Schaffhausen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

6.  Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication.

Authors:  Petra Mannová; Laura Beretta
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Shp2 suppresses PyMT-induced transformation in mouse fibroblasts by inhibiting Stat3 activity.

Authors:  Ying Yang; Beibei Jiang; Yingqing Huo; Luca Primo; Jean S Dahl; Thomas L Benjamin; Jincai Luo
Journal:  Virology       Date:  2010-11-05       Impact factor: 3.616

8.  A mouse polyomavirus-encoded microRNA targets the cellular apoptosis pathway through Smad2 inhibition.

Authors:  Chang Kyoo Sung; Hyungshin Yim; Erik Andrews; Thomas L Benjamin
Journal:  Virology       Date:  2014-08-20       Impact factor: 3.616

9.  Radiation-resistant and radiation-sensitive forms of host resistance to polyomavirus.

Authors:  J P Carroll; J S Fung; R T Bronson; E Razvi; T L Benjamin
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  The akt kinase: molecular determinants of oncogenicity.

Authors:  M Aoki; O Batista; A Bellacosa; P Tsichlis; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.